# Clinical trials recruiting in Netherlands: 1,972 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,972 trials recruiting or not yet recruiting with a site in Netherlands, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Netherlands: 1,972 rows for $98.60, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 27 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/netherlands

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,972
- Recruiting or not yet: 1,972
- Read on: November 19, 2026

## Trials

The 25 newest of 1,972, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07941349 | Comparison of Continuous Cardiac Rhythm Monitoring and Standard Care in Post-MI Patients With Significant Scar and Reduced LVEF | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Recruiting | Ventricular Arrhythmia | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941349) |
| November 16, 2026 | NCT07940309 | The imPAct of nutritioN on the Outcome of pancrEATic Surgery; Food for Thought. | Maastricht University Medical Center | Observational | Recruiting | Chronic Pancreatitis, Pancreatic Cancer, Periampullar Disease | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940309) |
| November 16, 2026 | NCT07939516 | Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome | Medisch Spectrum Twente | Phase 4 | Not yet recruiting | Acute Coronary Syndromes (ACS), Unstable Angina Pectoris, Myocardial Infarction (MI), STEMI, NSTEMI | 3,120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939516) |
| November 16, 2026 | NCT07938593 | Preventing Mood Disorders in High-risk Offspring: Protocol for the Randomized Controlled Trial of the MARIO Online Preventive Intervention... | Erasmus Medical Center | Not applicable | Recruiting | Mood Disorders, Mood Disorders in Children and Adolescents, Depressive Symptoms, Mania, Resilience, Psychological... | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938593) |
| November 12, 2026 | NCT07931144 | Neonatal AI-Based Early Warning System for Late-Onset Sepsis and Necrotizing Enterocolitis in the NICU: Assessment of Response and... | University Hospital, Antwerp | Not applicable | Not yet recruiting | Late Onset Neonatal Sepsis, Necrotizing Enterocolitis of Newborn | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931144) |
| November 10, 2026 | NCT07929831 | The Impact of Incretins on Fat-free Mass, Muscle Strength and Functional Capacity | Radboud University Medical Center | Observational | Recruiting | Obesity & Overweight | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929831) |
| November 10, 2026 | NCT07928505 | Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR. | TripleMed B.V. | Not applicable | Not yet recruiting | Endoleak After Endovascular Aneurysm Repair, Aortic Aneurysm Abdominal | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928505) |
| November 10, 2026 | NCT07928479 | Neoadjuvant Trastuzumab, Pertuzumab and Zongertinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-5 Study | The Netherlands Cancer Institute | Phase 1 | Not yet recruiting | HER2-positive Breast Cancer, Early Breast Cancer (EBC) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928479) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 9, 2026 | NCT07924371 | AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study | Hospital Universitari Vall d'Hebron Research Institute | Observational | Recruiting | Stroke, Ischemic Stroke, Intracerebral Hemorrhage, Transient Ischemic Attack, Atrial Fibrillation | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924371) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07909382 | Multi-biomarkers in DEE | Istituto Giannina Gaslini | Observational | Recruiting | Developmental and Epileptic Encephalopathies (DEE) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909382) |
| October 29, 2026 | NCT07903987 | Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease | University Medical Center Groningen | Phase 4 | Recruiting | Peyronie's Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903987) |
| October 28, 2026 | NCT07901881 | The Effect of Theory-driven Physiotherapy on Physical Activity in Knee OA. | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Knee Osteoarthritis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901881) |
| October 28, 2026 | NCT07899853 | In-situ vs Ex-situ Liver Preservation | Leiden University Medical Center | Not applicable | Recruiting | Liver Disease (Alcoholic or Not), Transplantation | 752 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899853) |
| October 26, 2026 | NCT07895342 | Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma | Radboud University Medical Center | Not applicable | Not yet recruiting | Hepatocellular Carcinoma Non-Resectable | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895342) |
| October 23, 2026 | NCT07892976 | The CORE Platform Trial | Copenhagen Trial Unit, Center for Clinical Intervention Research | Not applicable | Not yet recruiting | Coronary Revascularization, Coronary Artery Disease | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892976) |
| October 21, 2026 | NCT07887256 | Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE Study | Leiden University Medical Center | Observational | Not yet recruiting | Reconstructive Surgery, Flap Monitoring | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887256) |
| October 21, 2026 | NCT07886957 | AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Observational | Recruiting | Hemorrhagic Stroke, Intracerebral, Subarachnoid Haemorrhage (SAH), Postanoxic Coma | 825 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886957) |
| October 21, 2026 | NCT07886541 | VATS or Intrapleural Enzymatic Therapy for Patients With Empyema. | Amsterdam UMC | Phase 4 | Recruiting | Empyema, Pleural, Pleural Infections | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886541) |
| October 20, 2026 | NCT07883551 | AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery | Catharina Ziekenhuis Eindhoven | Observational | Not yet recruiting | Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883551) |
| October 20, 2026 | NCT07883252 | Prehospital Transfusion Outcomes in Traumatic Hemorrhage: a Prospective Cohort Study | Erasmus Medical Center | Observational | Not yet recruiting | Trauma Associated Hemorrhage | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883252) |
| October 20, 2026 | NCT07882290 | Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) Disease | Beyond Batten Disease Foundation | Phase 3 | Not yet recruiting | CLN3 | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882290) |
| October 19, 2026 | NCT07881224 | A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects | Basilea Pharmaceutica | Phase 1 | Recruiting | Healthy Adult Participants | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881224) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University Medical Center Groningen | Groningen | 156 |
| Amsterdam UMC | Amsterdam | 139 |
| Leiden University Medical Center | Leiden | 89 |
| University Medical Center Utrecht | Utrecht | 73 |
| Erasmus Medical Center | Rotterdam | 71 |
| Radboud University Medical Center | Nijmegen | 67 |
| UMC Utrecht | Utrecht | 61 |
| Maastricht University Medical Center | Maastricht | 58 |
| Erasmus Medisch Centrum | Rotterdam | 55 |
| Amsterdam University Medical Center | Amsterdam | 45 |
| Universitair Medisch Centrum Groningen | Groningen | 44 |
| Medisch Spectrum Twente | Enschede | 44 |
| Catharina Ziekenhuis | Eindhoven | 42 |
| Universitair Medisch Centrum Utrecht | Utrecht | 40 |
| Erasmus University Medical Center | Rotterdam | 35 |
| Maastricht UMC+ | Maastricht | 35 |
| Meander Medisch Centrum | Amersfoort | 34 |
| St. Antonius Ziekenhuis | Nieuwegein | 30 |
| Radboud UMC | Nijmegen | 29 |
| Leids Universitair Medisch Centrum | Leiden | 27 |
| Noordwest Ziekenhuisgroep | Alkmaar | 27 |
| Canisius Wilhelmina Ziekenhuis | Nijmegen | 26 |
| Catharina Hospital | Eindhoven | 25 |
| Maastricht UMC | Maastricht | 25 |
| St. Antonius Hospital | Nieuwegein | 25 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 5 |
| Phase 1 | 91 |
| Phase 1/2 | 101 |
| Phase 2 | 188 |
| Phase 2/3 | 49 |
| Phase 3 | 376 |
| Phase 4 | 71 |
| Not applicable | 571 |
| Observational | 520 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 74 |
| Carcinoma, Non-Small-Cell Lung | 70 |
| Breast Neoplasms | 55 |
| Colorectal Neoplasms | 43 |
| Prostatic Neoplasms | 42 |
| Heart Failure | 41 |
| Lung Neoplasms | 38 |
| Obesity | 36 |
| Coronary Artery Disease | 34 |
| Cardiovascular Diseases | 31 |
| Crohn Disease | 30 |
| Atrial Fibrillation | 27 |
| Esophageal Neoplasms | 27 |
| Neoplasm Metastasis | 26 |
| Melanoma | 24 |
| Glioblastoma | 22 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Motor Activity | 21 |
| Urinary Bladder Neoplasms | 20 |
| Recurrence | 20 |
| Ovarian Neoplasms | 20 |
| Multiple Myeloma | 19 |
| Glioma | 19 |
| Endometrial Neoplasms | 19 |
| Stomach Neoplasms | 19 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Erasmus Medical Center | 116 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 112 |
| University Medical Center Groningen | 110 |
| Radboud University Medical Center | 77 |
| Maastricht University Medical Center | 63 |
| Leiden University Medical Center | 60 |
| UMC Utrecht | 52 |
| Amsterdam UMC, location VUmc | 49 |
| The Netherlands Cancer Institute | 47 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 37 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 33 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 32 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 28 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 26 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 22 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 19 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 18 |
| St. Antonius Hospital | 18 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 14 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 13 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 13 |
| Princess Maxima Center for Pediatric Oncology | 12 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 12 |
| Wageningen University | 12 |
| European Organisation for Research and Treatment of Cancer - EORTC | 11 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
- [Biotechnology companies in the United States](https://specstream.ai/data/businesses/biotechnology-companies/united-states)
- [Burger restaurants in the United States](https://specstream.ai/data/businesses/burger-restaurants/united-states)
- [Cardiothoracic surgery practices in the United States](https://specstream.ai/data/businesses/cardiothoracic-surgery-practices/united-states)
- [Chimney sweeps in the United States](https://specstream.ai/data/businesses/chimney-sweeps/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
